Latest News

 
06/03/2015

Mazor Robotics Renaissance® Guidance System Helping Patients with OCD

Orlando, Fla., March Mazor Robotics Renaissance® Guidance System Helping Patients with OCD5Mazor Robotics, a global leader in the development and distribution of innovative surgical guidance systems for spine and brain surgery, announced today the first Deep Brain Stimulation (DBS) surgery performed with its Renaissance®Guidance System to treat patients with Obsessive Compulsive Disorder (OCD).

On February 23, 2015, Dr. David VanSickle of South Denver Neurosurgery was the first physician to utilize the Renaissance Guidance System to successfully perform the DBS procedure to treat OCD on 30-year-old twins at Littleton Adventist Hospital in Littleton, Colorado, part of Centura Health’s Neurosciences system of care.

“DBS involves placing implantable neurostimulators (electrodes) in targeted areas of the brain,” said Dr. VanSickle. He added, “The key is to place the device precisely inside the brain to minimize brain tissue damage. This is where the Renaissance® Guidance System comes into play. It allows me to increase surgical accuracy and precisely hold the trajectory. It is groundbreaking technology that is great news for patients suffering from this debilitating disease.”

After the procedure, all electrodes were verified by intra-operative CT to be placed in the intended location to an accuracy of less than a millimeter.

“This milestone is another testimony to our commitment to improving the art and science of spine and brain surgery, with one main focus: improving patient care,” said Ori Hadomi, CEO of Mazor Robotics.

According to the National Institute of Mental Health, OCD affects about 2.3% of the US population aged 18 to 54 years (3.3 million Americans). An additional one million children and adolescents have the disorder. If left untreated, OCD symptoms become progressively worse, making it difficult to function at school, at work, and at home. Treatment is therefore crucial. Initial approaches to OCD treatment include pharmacological, therapeutic, and self-help methods. However, when severe OCD proves resistant to the typical standard of care, physicians may turn to DBS as a surgical option.

About Mazor Robotics

Mazor Robotics (TASE: MZOR; NASDAQGM: MZOR) believes in healing through innovation by developing and introducing revolutionary robotic-based technology and products aimed at redefining the gold standard of quality care. Mazor Robotics Renaissance® Guidance System enables surgeons to conduct spine and brain procedures in a more accurate and secure manner.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other securities laws. Any statements in this release about future expectations, plans or prospects for Mazor Robotics, including without limitation, statements regarding the possibilities of the Renaissance system in DBS procedures for OCD, and other statements containing the words “believes,” “anticipates,” “plans,” “expects,” “will” and similar expressions are forward-looking statements. These statements are only predictions based on Mazor’s current expectations and projections about future events. There are important factors that could cause Mazor’s actual results, level of activity, performance or achievements to differ materially from the results, level of activity, performance or achievements expressed or implied by the forward-looking statements. Those factors include, but are not limited to, the impact of general economic conditions, competitive products, product demand and market acceptance risks, reliance on key strategic alliances, fluctuations in operating results, and other factors indicated in Mazor’s filings with the Securities and Exchange Commission (SEC) including those discussed under the heading “Risk Factors” in Mazor’s annual report on Form 20-F filed with the SEC on April 9, 2014 and in subsequent filings with the SEC. For more details, refer to Mazor’s SEC filings. Mazor undertakes no obligation to update forward-looking statements to reflect subsequent occurring events or circumstances, or to changes in our expectations, except as may be required by law.

19/02/2015

Mazor Debuts in Victoria

On the 22nd January 2015, LifeHealthcare achieved an important Mazor milestone with a successful first robotic case at the Valley Private Hospital. The L3-L5 TLIF open procedure with a scoliotic patient included the accurate and timely placement of 6 pedicle screws. Professor Richard Bittar, assisted by Mohammad Awad, commented after the case “The robot takes away the stress off pedicle screw placement” and “the screws are aligned with our preoperative plan”. The operation went smoothly with the operating team, LHC and Mazor personnel working in strong collaboration in the OR.

The case was performed following a comprehensive robotic training week with the LifeHealthcare integration team delivering didactic and hands-on workshops to the Valley’s surgeons, nurses, radiology, and sterilisation groups. The hospital CEO and management team have been highly engaged and are pleased with the clinical and commercial value the robot is expected to add to their hospital.

This significant event and subsequent successful robotic surgeries received national media attention. Following are links to articles and that discussed the procedures.

13/08/2014

Successful Validation with Mazor Robotics

Mazor Robotics RenaissanceTM robot executes highly accurate, complex spinal procedures delivering increase patient safety, fewer complications and requiring lower radiation doses as compared to traditional surgical intervention. Utilizing the images from a high quality pre-operative CT scan, attending surgeons carefully map out the procedure in a three-dimensional, virtual environment ensuring accurate placement of screws and implants. The images provided by NeuroLogica’s portable CT scanner BodyTomTM were proven to be compatible with Mazor’s planning software.

“We are pleased to announce the successful validation between the BodyTom and the Renaissance robot,” says Dr. Eric M. Bailey, CEO of NeuroLogica. “Soon patients across the globe will benefit from the combination of the superior images of BodyTom and the cutting edge technology developed by Mazor Robotics.”

“Compatibility of Mazor’s Renaissance robot with leading imaging products is important to our customers” said Ori Hadomi, CEO of Mazor Robotics. “So while surgeons can still use regular CT scanners for the planning, they can also use intra-operative CTs, such as BodyTom, which are quickly gaining popularity with them.”

NeuroLogica’s BodyTom™ is a completely portable, full body 32 slice CT that boasts an 85cm gantry and 60cm field of view. The battery powered BodyTom™ can be transported from room to room providing high quality CT images in the clinic, ICU, OR and Emergency/Trauma Department. BodyTom™ is DICOM 3.1 compliant and compatible with all PACS, surgical navigation, surgical robots, electronic medical records and planning systems.